Medication-related problems and their associated factors among paediatric patients in Ethiopia: a systematic review and meta-analysis
Open Access
- 13 January 2026
- journal article
- research article
- Published by BMJ in BMJ Paediatrics Open
- Vol. 10 (1) , e004113
Abstract
Background: Medication-related problems are a significant global public health concern, with children being particularly vulnerable due to factors like weight-based dosing and immature organ function. In low-resource settings like Ethiopia, the burden is suspected to be high, but a comprehensive national estimate has been lacking. Objective: This systematic review and meta-analysis aimed to determine the pooled prevalence of medication-related problems and their associated factors among paediatric patients in Ethiopia. Method: A comprehensive search was conducted across PubMed, Google Scholar, Science Direct and Hinari-Research4Life and manual reference search from 1 to 10 September 2025, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies reporting data on medication-related problems (including medication errors, adverse drug reactions and drug therapy problems) in Ethiopian children were included. Data extraction and quality assessment were performed by independent reviewers. Heterogeneity was assessed using I 2 statistics; moderate heterogeneity (I 2 =39.4%) was observed and a random-effect model was used. Subgroup analysis and meta-regression were applied to explore the source of heterogeneity. Result: Out of 3435 initially identified articles, 21 hospital-based studies involving 5969 paediatric patients were included. The pooled prevalence of medication-related problems across these studies was 53% (95% CI 45% to 61%) with a pooled incidence rate of 1.17 medication-related problems per child and a moderate level of heterogeneity. The pooled prevalence of dosing error was 37.4%. Additionally, 51% of children had comorbid conditions and 42% were exposed to polypharmacy. Both polypharmacy (≥5 medications: pooled OR=1.32; 95% CI 1.13 to 1.52) and the presence of comorbidity (pooled OR=1.32; 95% CI 1.02 to 1.61) were significantly associated factors of medication-related problems. Conclusion: More than half of the paediatric patients in Ethiopia experience medication-related problems. Polypharmacy and comorbidities are major contributing factors. Therefore, comprehensive medication review and monitoring are needed to mitigate this substantial burden.Keywords
This publication has 59 references indexed in Scilit:
- Infusion Medication Error Reduction by Two-Person Verification: A Quality Improvement InitiativePediatrics, 2016
- Incidence and determinants of medication errors and adverse drug events among hospitalized children in West EthiopiaBMC Pediatrics, 2016
- Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational studyBMC Pediatrics, 2015
- Epidemiology of medication-related problems in children with kidney diseasePediatric Nephrology, 2014
- ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methodsProgramme Grants for Applied Research, 2014
- Epidemiology and potential risk factors of drug‐related problems in Hong Kong paediatric wardsBritish Journal of Clinical Pharmacology, 2014
- The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalenceInternational Journal of Health Policy and Management, 2014
- Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi ArabiaEuropean Journal of Clinical Pharmacology, 2012
- Adverse Drug Reactions in Children—A Systematic ReviewPLOS ONE, 2012
- International drug monitoring: the role of national centres. Report of a WHO meeting.1972